- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05787067
The Effect of Mobile Online Training Applied to Patients With Diabetes on Insulin Therapy
March 24, 2023 updated by: Büşra Ceren DEMİREL YILDIZ, Ataturk University
The Effect of Health Belief Model-Based Mobile Online Training Applied to Patients With Diabetes on Insulin Therapy
This study aims to investigate the effect of health belief model-based mobile online training applied to patients with diabetes on insulin therapy.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Intervention and control group participants were invited to the Endocrinology and Metabolic Diseases Outpatient Clinic for a pre-test.
n addition, each group was given insulin injection practice training using an insulin injection model.
Whether the application was correct, incomplete, or incorrect was recorded on the observation form by the diabetes nurse.
The web-based "Insulin Guide" mobile application prepared by the researcher was installed on the phones of the intervention group participants.
They were asked to use this application for three months, at least three hours a week.
Participants were followed up through the application.
Participants who did not use the application were informed by SMS or phone and asked to use the application.
Participants who did not use the application were excluded from the study.
No intervention was made for the control group participants.
At the end of three months, the participants in the intervention and control groups were invited to the Endocrinology and Metabolic Diseases Outpatient Clinic for a post-test.
Both groups were asked to practice again on the insulin injection model.
Whether the application was correct, incomplete, or incorrect was recorded on the observation form by the diabetes nurse.
Study Type
Interventional
Enrollment (Actual)
148
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Erzurum, Turkey
- Ataturk Universty
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Research Inclusion Criteria
- Type 1 DM
- Type 2 DM (Diagnosed at least six months ago)
- Patients receiving insulin therapy
- Patients in the 18-65 age group
- Literate patients
- Patients, or patients with a relative, who has an electronic device such as a smartphone, computer, etc. that can connect to the Internet.
- Patients who have no psychiatric illness or communication barrier (visual, auditory, and speech disability)
- Individuals who agreed to participate in the research.
Research Exclusion Criteria
- Patients who receive treatment with oral anti-DM only
- Patients who use an insulin pump
- Patients who quit the training.
- Patients who had a change in treatment
- Patients who traveled to a place that cannot provide an Internet connection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
The web-based "Insulin Guide" mobile application prepared by the researcher was installed on the phones of the intervention group participants.
They were asked to use this application for three months, at least three hours a week.
Participants were followed up through the application.
Participants who did not use the application were informed by SMS or phone and asked to use the application.
Participants who did not use the application were excluded from the study.
At the end of three months, the participants in the intervention groups were invited to the Endocrinology and Metabolic Diseases Outpatient Clinic for a post-test.
Both groups were asked to practice again on the insulin injection model.
Whether the application was correct, incomplete, or incorrect was recorded on the observation form by the diabetes nurse.
|
Health Belief Model-Based Mobile Online Training
|
|
No Intervention: control group
Control group participants were invited to the Endocrinology and Metabolic Diseases Polyclinic for the pre-test.
They were asked to administer insulin injections using an insulin injection model.
Whether the application was correct, incomplete or incorrect was recorded in the observation form by the diabetes nurse.
No intervention was made to the participants.
At the end of three months, the participants in the control group were invited to the Endocrinology and Metabolic Diseases Polyclinic for the final test.
And they were asked to repeat the insulin injection model.
Whether the application was correct, incomplete or incorrect was recorded in the observation form by the diabetes nurse.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of Participants' Metabolic Variables (Body Mass Index (BMI)
Time Frame: Three months
|
The metabolic variables (Body Mass Index) of the individuals in the experimental and control groups were taken from hospital records and evaluated.
With the developed web-based mobile "Insulin Guide" application, the experimental group was trained for three months.
No intervention was made in the control group.
Three months later, the BMI values of individuals in both the experimental and control groups were re-evaluated from the hospital records.
|
Three months
|
|
Evaluation of Participants' Metabolic Variables ( Fasting Blood Sugar (FBS))
Time Frame: Three months
|
The metabolic variables (Fasting Blood Sugar) of the individuals in the experimental and control groups were evaluated by taking them from the hospital records.
With the developed web-based mobile "Insulin Guide" application, the experimental group was trained for three months.
No intervention was made in the control group.
Three months later, the FBC values of individuals in both the experimental and control groups were re-evaluated from the hospital records.
|
Three months
|
|
Evaluation of Participants' Metabolic Variables (High Density Lipoprotein (HDL))
Time Frame: Three months
|
The metabolic variables (High Density Lipoprotein) of the individuals in the experimental and control groups were evaluated from hospital records.
With the developed web-based mobile "Insulin Guide" application, the experimental group was trained for three months.
No intervention was made in the control group.
Three months later, HDL values of individuals in both the experimental and control groups were re-evaluated from hospital records.
|
Three months
|
|
Evaluation of Participants' Metabolic Variables (Low Density Lipoprotein (LDL))
Time Frame: Three months
|
The metabolic variables (Low Density Lipoprotein) of the individuals in the experimental and control groups were evaluated from hospital records.
With the developed web-based mobile "Insulin Guide" application, the experimental group was trained for three months.
No intervention was made in the control group.
Three months later, the LDL values of individuals in both the experimental and control groups were re-evaluated from the hospital records.
|
Three months
|
|
Evaluation of Participants' Metabolic Variables (HgA1C)
Time Frame: Three months
|
HgA1C, one of the metabolic variables of the individuals in the experimental and control groups, was taken from hospital records and evaluated.
With the developed web-based mobile "Insulin Guide" application, the experimental group was trained for three months.
No intervention was made in the control group.
Three months later, HgA1C values of individuals in both the experimental and control groups were re-evaluated from hospital records.
|
Three months
|
|
Evaluation of Participants' Self-Management of Insulin Therapy
Time Frame: Three months
|
Insulin therapy self-management of individuals in the experimental and control groups was evaluated with the "Insulin Therapy Self-Management Scale".
With the developed web-based mobile "Insulin Guide" application, the experimental group was trained for three months.
No intervention was made in the control group.
Three months later, the insulin therapy self-management of individuals in both the experimental and control groups was re-evaluated with the "Insulin Therapy Self-Management Scale".
"Insulin Therapy Self-Management Scale" is a scale used to evaluate the knowledge-skill levels and positive-negative attitudes of individuals with diabetes towards insulin therapy.
The increase in the scores obtained in all sub-dimensions indicates that the self-management levels in that dimension increase.
|
Three months
|
|
Evaluation of Participants' Health Belief Attitudes and Behaviors
Time Frame: Three months
|
The health belief attitudes and behaviors of the individuals in the experimental and control groups were evaluated with the "Health Belief Model Scale".
With the developed web-based mobile "Insulin Guide" application, the experimental group was trained for three months.
No intervention was made in the control group.
Three months later, the health belief attitudes and behaviors of individuals in both the experimental and control groups were re-evaluated using the "Health Belief Model Scale".
The scale used to evaluate the health belief attitudes and health behaviors of individuals with diabetes consists of a total of 33 items.
If the score obtained from the scale is four and above, it indicates positive health belief, and if it is less than four, it indicates negative health belief.
|
Three months
|
|
Evaluation of Participants' Insulin Injection Administration Skill Levels
Time Frame: Three months
|
The insulin injection application skill levels of the individuals in the experimental and control groups were evaluated with the "Insulin Injection Skill Observation Form" prepared by the researcher in line with the literature.
With the developed web-based mobile "Insulin Guide" application, the experimental group was trained for three months.
No intervention was made in the control group.
Three months later, the insulin injection skill levels of both the experimental and control groups were re-evaluated with the "Insulin Injection Skill Observation Form".
"Insulin Injection Skill Observation Form" was developed with the aim of objectively evaluating insulin injection application performance.
It consists of 21 items in total.
If the patient did the application wrong, he/she gets 0 points, if he/she did it incompletely, he/she gets 1 point, and if he/she did it completely, he/she gets 2 points.
The higher the average score, the higher will be their insulin injection skill level.
|
Three months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 30, 2021
Primary Completion (Actual)
December 30, 2022
Study Completion (Actual)
February 20, 2023
Study Registration Dates
First Submitted
February 22, 2023
First Submitted That Met QC Criteria
March 24, 2023
First Posted (Actual)
March 28, 2023
Study Record Updates
Last Update Posted (Actual)
March 28, 2023
Last Update Submitted That Met QC Criteria
March 24, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BÜŞRA TEZ
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
ENBIOSIS BIOTECHNOLOGIESAydin Adnan Menderes University; Izmir University of Economics; Buca Seyfi Demirsoy... and other collaboratorsRecruitingType 2 Diabetes | Diabetes Mellitus Type 2Turkey (Türkiye)
-
Instituto Nacional de Ciencias Medicas y Nutricion...Active, not recruiting
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes Mellitus | Type 2 Diabetes | Type2diabetes
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type2Diabetes
-
University of SalamancaUniversity of Salamanca; Instituto Piaget; Escola Superior de Tecnologia da Saúde...Enrolling by invitationType 2 Diabetes Mellitus | Aging | Hyperglycemia Due to Type 2 Diabetes MellitusPortugal
-
Kaiser PermanenteThe Permanente Medical GroupEnrolling by invitationType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2D)United States
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Ohio State UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruitingT2DM (Type 2 Diabetes Mellitus)United States
-
San Diego State UniversityUniversity of California, Berkeley; National Institute on Minority Health and...RecruitingDiabetes Mellitus | Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus Type 2 (T2DM)United States
Clinical Trials on Health Belief Model-Based Mobile Online Training
-
Aydin Adnan Menderes UniversityCompletedTHE HEALTH BELIEF MODEL ON THE PHYSICAL ACTIVITY BELIEFSTurkey
-
Marmara UniversityNot yet recruitingBreast Cancer Awareness and BSE in Visually Impaired WomenTurkey
-
Ataturk UniversityCompleted
-
Muhammet Faruk YigitNot yet recruitingCervical Cancer | Human Papillomavirus Infection | Preventive Health Services
-
Sakarya UniversityThe Scientific and Technological Research Council of TurkeyNot yet recruitingHealth Behaviour | Risk Behavior, Health
-
Ege UniversityCompletedHemodialysis | PruritusTurkey (Türkiye)
-
Yuzuncu Yıl UniversityAtaturk UniversityCompletedType2 Diabetes MellitusTurkey
-
Kafkas UniversityNot yet recruitingBreast Cancer | Breast Self-ExaminationTurkey (Türkiye)
-
Saglik Bilimleri UniversitesiCompletedEducation | Health Belief ModelTurkey (Türkiye)